| Product Code: ETC6748574 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Next Generation Bio therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Next Generation Bio therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Next Generation Bio therapeutics Market - Industry Life Cycle |
3.4 China Next Generation Bio therapeutics Market - Porter's Five Forces |
3.5 China Next Generation Bio therapeutics Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
3.6 China Next Generation Bio therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 China Next Generation Bio therapeutics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 China Next Generation Bio therapeutics Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 China Next Generation Bio therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China, driving the demand for advanced biotherapeutics. |
4.2.2 Government initiatives to promote research and development in the biotechnology sector. |
4.2.3 Growing investments from both domestic and international pharmaceutical companies in the Chinese biotherapeutics market. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of next-generation biotherapeutics in China. |
4.3.2 Limited awareness and acceptance of advanced biotherapeutics among healthcare professionals and patients in the country. |
5 China Next Generation Bio therapeutics Market Trends |
6 China Next Generation Bio therapeutics Market, By Types |
6.1 China Next Generation Bio therapeutics Market, By Therapeutic Application |
6.1.1 Overview and Analysis |
6.1.2 China Next Generation Bio therapeutics Market Revenues & Volume, By Therapeutic Application, 2021- 2031F |
6.1.3 China Next Generation Bio therapeutics Market Revenues & Volume, By Oncology Next-Generation Antibody Therapeutics, 2021- 2031F |
6.1.4 China Next Generation Bio therapeutics Market Revenues & Volume, By Autoimmune/Inflammatory Next-Generation Antibody Therapeutics, 2021- 2031F |
6.2 China Next Generation Bio therapeutics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 China Next Generation Bio therapeutics Market Revenues & Volume, By Antibody-Drug Conjugates (ADCs), 2021- 2031F |
6.2.3 China Next Generation Bio therapeutics Market Revenues & Volume, By Bispecific Antibodies Market, 2021- 2031F |
6.2.4 China Next Generation Bio therapeutics Market Revenues & Volume, By Fc-engineered Antibodies, 2021- 2031F |
6.2.5 China Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Next Generation Bio therapeutics Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 China Next Generation Bio therapeutics Market Revenues & Volume, By Brentuximab Vedotin, 2021- 2031F |
6.3.3 China Next Generation Bio therapeutics Market Revenues & Volume, By Trastuzumab, 2021- 2031F |
6.3.4 China Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Next Generation Bio therapeutics Market, By End- Users |
6.4.1 Overview and Analysis |
6.4.2 China Next Generation Bio therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 China Next Generation Bio therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 China Next Generation Bio therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 China Next Generation Bio therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Next Generation Bio therapeutics Market Import-Export Trade Statistics |
7.1 China Next Generation Bio therapeutics Market Export to Major Countries |
7.2 China Next Generation Bio therapeutics Market Imports from Major Countries |
8 China Next Generation Bio therapeutics Market Key Performance Indicators |
8.1 Research and development expenditure in the biotechnology sector in China. |
8.2 Number of clinical trials for next-generation biotherapeutics conducted in China. |
8.3 Adoption rate of innovative biotherapeutics in Chinese healthcare facilities. |
9 China Next Generation Bio therapeutics Market - Opportunity Assessment |
9.1 China Next Generation Bio therapeutics Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
9.2 China Next Generation Bio therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 China Next Generation Bio therapeutics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 China Next Generation Bio therapeutics Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 China Next Generation Bio therapeutics Market - Competitive Landscape |
10.1 China Next Generation Bio therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Next Generation Bio therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here